Literature DB >> 19864147

Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker.

Natascha Chavain1, Elisabeth Davioud-Charvet, Xavier Trivelli, Linda Mbeki, Matthias Rottmann, Reto Brun, Christophe Biot.   

Abstract

Based on the prodrug concept as well as the combination of two different classes of antimalarial agents, we designed and synthesized two series of ferrocenic antimalarial dual molecules consisting of a ferroquine analogue conjugated with a glutathione reductase inhibitor (or a glutathione depletor) through a cleavable amide bond in order to target two essential pathways in the malarial parasites. The results showed no enhancement of the antimalarial activity of the dual molecules but evidenced a unique mode of action of ferroquine and ferrocenyl analogues distinct of those of chloroquine and nonferrocenic 4-aminoquinoline analogues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864147     DOI: 10.1016/j.bmc.2009.10.008

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Huprines as a new family of dual acting trypanocidal-antiplasmodial agents.

Authors:  Julien Defaux; Marta Sala; Xavier Formosa; Carles Galdeano; Martin C Taylor; Waleed A A Alobaid; John M Kelly; Colin W Wright; Pelayo Camps; Diego Muñoz-Torrero
Journal:  Bioorg Med Chem       Date:  2011-01-21       Impact factor: 3.641

Review 2.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 3.  The antimalarial ferroquine: from bench to clinic.

Authors:  C Biot; F Nosten; L Fraisse; D Ter-Minassian; J Khalife; D Dive
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

4.  Current developments in the therapy of protozoan infections.

Authors:  Mario Zucca; Dianella Savoia
Journal:  Open Med Chem J       Date:  2011-03-09

Review 5.  Quinoline-Based Hybrid Compounds with Antimalarial Activity.

Authors:  Xhamla Nqoro; Naki Tobeka; Blessing A Aderibigbe
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

Review 6.  Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.

Authors:  Sijongesonke Peter; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2019-10-07       Impact factor: 4.411

Review 7.  Ferroquine and its derivatives: new generation of antimalarial agents.

Authors:  Waseem A Wani; Ehtesham Jameel; Umair Baig; Syed Mumtazuddin; Lee Ting Hun
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.